1.Efficacy of N-acetylcysteine plus beta-blocker versus beta-blocker alone in preventing postoperative atrial fibrillation after cardiac surgery: A meta-analysis of randomized controlled trials
Giovanni Vista ; Von Jerick B. Tenorio ; Marivic V. Vestal
Philippine Journal of Cardiology 2025;53(1):73-86
BACKGROUND
Postoperative atrial fibrillation (POAF) is the most common arrythmia to occur after cardiovascular surgery. Inflammation being pivotal in POAF perpetuation has been utilized as a therapeutic target. Owing to their anti-inflammatory and anti-oxidant effects, beta-blockers (BB) and N-acetylcysteine (NAC) became research interests in the pursuit for an effective POAF prevention strategy.
OBJECTIVETo determine the efficacy of NAC plus BB versus BB alone in preventing POAF in cardiac surgery patients.
METHODOLOGYA literature search using the following search engines: PubMed/Medline, Cochrane Review Central, Clinical Trials Registry, ResearchGate, Mendeley and Google Scholar for relevant randomized trials were conducted. Published and unpublished studies indexed from inception until 2023 were included. Three independent reviewers evaluated the randomized clinical trials (RCTs) for eligibility. The pooled estimates for POAF prevention as primary outcome and MACE, mortality, myocardial infarction, stroke, ICU LOS and hospital LOS as secondary outcomes were measured using the RStudio statistical software.
RESULTSSeven eligible RCTs allocated 1069 cardiac surgery patients to NAC + BB (n=539) and BB alone (N = 530) treatment arms. The effect estimate using random effect model disclosed significantly reduced POAF events (RR 0.62, 95% CI [0.44, 0.86], p = 0.005) in those on NAC + BB. While no statistical difference between the study arms were demonstrated in reducing mortality (RR 0.63, 95% CI [0.23, 1.73], p = 0.37); myocardial infarction (RR 1.02, 95% CI [0.49, 2.13], p = 0.96); stroke (RR 0.95, 95% CI [0.24, 3.68], p = 0.94); ICU LOS (std. mean difference 0.14, 95% CI [-0.43, 0.70], p = 0.41), and hospital LOS (std. mean difference 0.08, 95% CI [-0.06, 0.21], p = 0.19).
CONCLUSIONAmong cardiac surgery patients, the use of NAC in combination with BB compared with BB alone significantly reduced POAF.
Acetylcysteine ; Arrhythmias, Cardiac ; Atrial Fibrillation ; Myocardial Infarction ; Omega-chloroacetophenone
2.A comparison of the performance of SVEAT score versus HEART score in predicting in-hospital MACE in patients admitted for chest pain
Philippine Journal of Internal Medicine 2025;63(3):5-15
BACKGROUND
Chest pain is a common reason for emergency room visits. The HEART score is used as a risk stratification tool to aid in clinical decision making. The HEART score is a useful tool due to its good sensitivity, however it has low specificity. The SVEAT score was developed as an improved risk stratification tool which outperformed the HEART score in previous studies. Both the performance of HEART and SVEAT scores lack data in our locality.
OBJECTIVETo compare the performance of Symptoms, Vascular disease, Electrocardiography, Age, Troponin-I (SVEAT) score and History, Electrocardiography, Age, Risk factors, Troponin-I (HEART) score as predictors of in-hospital Major Adverse Cardiovascular Events (MACE) among adult patients admitted in Chong Hua Hospital Cebu for chest pain.
METHODSThis single-center, retrospective, observational analytic study included adult patients, ages 18 years old and above, who were admitted for chest pain from January 1, 2022 to December 31, 2022. All patients who passed the inclusion and exclusion criteria were included in the data analysis. Both SVEAT and HEART scores were calculated for each of the included subjects. The performance of both scoring criteria was compared using logistic regression and area under the receiving-operator characteristic curve.
RESULTSA total of 113 cases were analyzed after exclusion criteria were applied. A total of 50 (44.2%) individuals suffered MACE. The difference in AUC of both SVEAT (0.946, 95%CI) and HEART (0.936, 95%CI) was not statistically significant (95% CI – 0.013 – 0.033, p = 0.400). With a cut-off ofCONCLUSION
SVEAT and HEART scores had similar performance in predicting in hospital MACE. Using a cut-off value of
Human
;
Chest Pain
;
Heart
;
Myocardial Infarction
;
Acute Coronary Syndrome
3.Performance measures in the management of ST-segment elevation myocardial infarction patients at Manila Doctors Hospital
Michelle Gotohio-Ong ; Vhina Therese P. Sison ; Joy-anezka S. Guzman ; April Ann A. Bermudez-delos Santos ; Wilbert Allan G. Gumatay ; Noemi S. Pestañ ; o ; Bernadette A. Tumanan-Mendoza ; Felix Eduardo R. Punzalan
Philippine Journal of Cardiology 2024;52(2):12-22
INTRODUCTION
ST-segment elevation myocardial infarction (STEMI) is a common and potentially fatal presentation of cardiovascular disease. Once a diagnosis is made, prompt intervention is crucial, with substantial effect on morbidity and even mortality.
OBJECTIVEThe aim of this study was to assess the adherence of physicians of a tertiary care hospital to American College of Cardiology/American Heart Association and European Society of Cardiology performance measures for the management of acute STEMI patients.
METHODOLOGYThis was a descriptive retrospective chart review of acute STEMI patients seen in a tertiary care hospital over a 2-year period.
RESULTSA total of 118 STEMI patients were included in the study. Mean age was 57.8 years with male predominance. High adherence rates (100% achievement score) to recommended discharge medications and counseling for smoking cessation were observed. However, performance measures for time to reperfusion therapy via percutaneous coronary intervention (average, 16.7% over 2 years) and referral to cardiac rehabilitation (average, 38.0%) were consistently low, although time to percutaneous coronary intervention improved from an average of 170 minutes to 142 minutes in the second year of this study.
CONCLUSIONFor 2 consecutive years, all STEMI patients seen in our institution were adequately managed with regard to recommended medications. All patients have been advised lifestyle change, particularly smoking cessation for current smokers. There is room for improvement with regards to time to reperfusion therapy and referral to cardiac rehabilitation. Some measures have been suggested, including shortening the time to secure patient consent.
Myocardial Infarction ; St Elevation Myocardial Infarction ; Stemi
4.A cross-sectional study on the association of red cell distribution width and Acute Coronary Syndrome among patients admitted to the Bataan General Hospital and Medical Center
Monica B. Alagon ; Almalyn C. Sevilla
Philippine Journal of Internal Medicine 2024;62(1):262-266
Introduction:
Red cell distribution width (RDW) is a parameter that is readily available as part of a standard complete blood
count (CBC). Studies have shown that an elevated RDW is associated with increased cardiovascular events including acute
coronary syndrome (ACS). This cross- sectional retrospective study was conducted to determine the association of RDW in
patients with ACS admitted to Bataan General Hospital and Medical Center (BGHMC).
Methods:
A cross-sectional study was performed in a 500-bed tertiary care hospital in Bataan, Philippines. The clinical
medical records of patients with ACS were analyzed retrospectively. A total of 811 patients was admitted as cases of ACS
from January 2017 to December 2019. Using Slovin’s formula, the computed sample size was 261 patients. However, only
205 cases were included in the study in accordance to the eligibility criteria. The baseline RDW were recorded from the
CBC obtained upon admission of patients with ACS.
Results:
Based on the data collected from January 2017 to December 2019 from patients admitted to BGHMC, there was
no significant association between RDW and in-house morbidity and mortality and classification of ACS.
Conclusions
There were no significant association between RDW and in-house morbidity and mortality and classification
of ACS. The authors recommend to conduct the study for a longer duration to have more population included and to
include other parameters such as cardiac enzymes, electrocardiogram (ECG) changes and presence of co-morbidities.
Erythrocyte Indices
;
Acute Coronary Syndrome
;
Angina, Unstable
;
ST Elevation Myocardial Infarction
5.Alcohol, coronary artery disease with myocardial infraction, lifestyle medicine: A case study
Vigilanda M. Solijon, MD, MHM-MBA, DPCLM
The Filipino Family Physician 2023;61(1):15-20
This 63 year old, heavy drinker, previous smoker man, was physically active, a community leader and with good sleeping habits. His diet: processed foods and drinks, meat, poultry products; minimal fruits and vegetables added about a year earlier. Two weeks prior, after drinking alcohol, he experienced progressive difficulty of breathing on physical exertion, relieved by rest. The night before the incident he had a drinking spree. Early morning, he had severe shortness of breath, difficulty of breathing and chest heaviness. He was rushed to the nearby hospital, was admitted at the ICU with the diagnosis of Ischemic Heart Disease with Myocardial Infarction, and, Type 2 Diabetes. The diagnosis was sustained and the management continued upon transfer to a better-equipped hospital. Strict nutritional prescription was introduced and early ambulation started while still in the hospital. His medications were steeply tapered off while lifestyle modification intensified. His progress was extraordinary. This case exemplified the havoc of heavy alcohol drinking, and, its uneventful cold turkey abstinence; favored early ambulation post myocardial infarction, and showed the independence of each CVD risk factor. Is intensive Lifestyle Modification safe and beneficial even in morbid situations?
Coronary artery disease
;
myocardial infarction
;
alcohol consumption
7.Diabetes mellitus and adverse outcomes after carotid endarterectomy: A systematic review and meta-analysis.
Fengshi LI ; Rui ZHANG ; Xiao DI ; Shuai NIU ; Zhihua RONG ; Changwei LIU ; Leng NI
Chinese Medical Journal 2023;136(12):1401-1409
BACKGROUND:
There is still uncertainty regarding whether diabetes mellitus (DM) can adversely affect patients undergoing carotid endarterectomy (CEA) for carotid stenosis. The aim of the study was to assess the adverse impact of DM on patients with carotid stenosis treated by CEA.
METHODS:
Eligible studies published between 1 January 2000 and 30 March 2023 were selected from the PubMed, EMBASE, Web of Science, CENTRAL, and ClinicalTrials databases. The short-term and long-term outcomes of major adverse events (MAEs), death, stroke, the composite outcomes of death/stroke, and myocardial infarction (MI) were collected to calculate the pooled effect sizes (ESs), 95% confidence intervals (CIs), and prevalence of adverse outcomes. Subgroup analysis by asymptomatic/symptomatic carotid stenosis and insulin/noninsulin-dependent DM was performed.
RESULTS:
A total of 19 studies (n = 122,003) were included. Regarding the short-term outcomes, DM was associated with increased risks of MAEs (ES = 1.52, 95% CI: [1.15-2.01], prevalence = 5.1%), death/stroke (ES = 1.61, 95% CI: [1.13-2.28], prevalence = 2.3%), stroke (ES = 1.55, 95% CI: [1.16-1.55], prevalence = 3.5%), death (ES = 1.70, 95% CI: [1.25-2.31], prevalence =1.2%), and MI (ES = 1.52, 95% CI: [1.15-2.01], prevalence = 1.4%). DM was associated with increased risks of long-term MAEs (ES = 1.24, 95% CI: [1.04-1.49], prevalence = 12.2%). In the subgroup analysis, DM was associated with an increased risk of short-term MAEs, death/stroke, stroke, and MI in asymptomatic patients undergoing CEA and with only short-term MAEs in the symptomatic patients. Both insulin- and noninsulin-dependent DM patients had an increased risk of short-term and long-term MAEs, and insulin-dependent DM was also associated with the short-term risk of death/stroke, death, and MI.
CONCLUSIONS
In patients with carotid stenosis treated by CEA, DM is associated with short-term and long-term MAEs. DM may have a greater impact on adverse outcomes in asymptomatic patients after CEA. Insulin-dependent DM may have a more significant impact on post-CEA adverse outcomes than noninsulin-dependent DM. Whether DM management could reduce the risk of adverse outcomes after CEA requires further investigation.
Humans
;
Endarterectomy, Carotid/adverse effects*
;
Carotid Stenosis/surgery*
;
Risk Factors
;
Treatment Outcome
;
Time Factors
;
Stents/adverse effects*
;
Diabetes Mellitus, Type 2/complications*
;
Diabetes Mellitus, Type 1
;
Stroke/complications*
;
Insulin/therapeutic use*
;
Myocardial Infarction/complications*
;
Risk Assessment
8.Impact of Smoke-Free Legislation on Acute Myocardial Infarction and Subtypes of Stroke Incidence in Shenzhen, China, 2012-2016: An Interrupted Time Series Analysis.
Yu Lin SHI ; Jing Fan XIONG ; Li Qun LIU ; Zhi Guang ZHAO ; Xia WAN ; Ji PENG
Biomedical and Environmental Sciences 2023;36(6):527-536
OBJECTIVE:
This study assesses the impact of smoke-free legislation on the incidence rate for acute myocardial infarction (AMI) and stroke in Shenzhen.
METHODS:
Data on ischemic ( n = 72,945) and hemorrhagic ( n = 18,659) stroke and AMI ( n = 17,431) incidence covering about 12 million people in Shenzhen from 2012 to 2016 were used. Immediate and gradual changes in incidence rates were analyzed using segmented Poisson regression.
RESULTS:
Following the smoke-free legislation, a 9% (95% CI: 3%-15%) immediate reduction was observed in AMI incidence, especially in men (8%, 95% CI: 1%-14%) and in those aged 65 years and older (17%, 95% CI: 9%-25%). The gradual annual benefits were observed only in hemorrhagic and ischemic stroke incidence, with a 7% (95% CI: 2%-11%) and 6% (95% CI: 4%-8%) decrease per year, respectively. This health effect extended gradually to the 50-64 age group. In addition, neither the immediate nor gradual decrease in stroke and AMI incidence rates did not show statistical significance among the 35-49 age group ( P > 0.05).
CONCLUSION
Smoke-free legislation was enforced well in Shenzhen, which would generate good experiences for other cities to enact and enforce smoke-free laws. This study also provided more evidence of the health benefits of smoke-free laws on stroke and AMI.
Male
;
Humans
;
Middle Aged
;
Adult
;
Incidence
;
Interrupted Time Series Analysis
;
Stroke/etiology*
;
Myocardial Infarction/etiology*
;
China/epidemiology*
;
Tobacco Smoke Pollution
9.Exploring the Feasibility of Machine Learning to Predict Risk Stratification Within 3 Months in Chest Pain Patients with Suspected NSTE-ACS.
Zhi Chang ZHENG ; Wei YUAN ; Nian WANG ; Bo JIANG ; Chun Peng MA ; Hui AI ; Xiao WANG ; Shao Ping NIE
Biomedical and Environmental Sciences 2023;36(7):625-634
OBJECTIVE:
We aimed to assess the feasibility and superiority of machine learning (ML) methods to predict the risk of Major Adverse Cardiovascular Events (MACEs) in chest pain patients with NSTE-ACS.
METHODS:
Enrolled chest pain patients were from two centers, Beijing Anzhen Emergency Chest Pain Center Beijing Bo'ai Hospital, China Rehabilitation Research Center. Five classifiers were used to develop ML models. Accuracy, Precision, Recall, F-Measure and AUC were used to assess the model performance and prediction effect compared with HEART risk scoring system. Ultimately, ML model constructed by Naïve Bayes was employed to predict the occurrence of MACEs.
RESULTS:
According to learning metrics, ML models constructed by different classifiers were superior over HEART (History, ECG, Age, Risk factors, & Troponin) scoring system when predicting acute myocardial infarction (AMI) and all-cause death. However, according to ROC curves and AUC, ML model constructed by different classifiers performed better than HEART scoring system only in prediction for AMI. Among the five ML algorithms, Linear support vector machine (SVC), Naïve Bayes and Logistic regression classifiers stood out with all Accuracy, Precision, Recall and F-Measure from 0.8 to 1.0 for predicting any event, AMI, revascularization and all-cause death ( vs. HEART ≤ 0.78), with AUC from 0.88 to 0.98 for predicting any event, AMI and revascularization ( vs. HEART ≤ 0.85). ML model developed by Naïve Bayes predicted that suspected acute coronary syndrome (ACS), abnormal electrocardiogram (ECG), elevated hs-cTn I, sex and smoking were risk factors of MACEs.
CONCLUSION
Compared with HEART risk scoring system, the superiority of ML method was demonstrated when employing Linear SVC classifier, Naïve Bayes and Logistic. ML method could be a promising method to predict MACEs in chest pain patients with NSTE-ACS.
Humans
;
Acute Coronary Syndrome/epidemiology*
;
Bayes Theorem
;
Feasibility Studies
;
Risk Assessment/methods*
;
Chest Pain/etiology*
;
Myocardial Infarction/diagnosis*
10.Relationship between pyroptosis and cardiovascular diseases and traditional Chinese medicine prevention and treatment research.
Zi-Qin LEI ; Fei LUAN ; Ming GAO ; Jing-Wen HU ; Nan ZENG
China Journal of Chinese Materia Medica 2023;48(7):1779-1791
Pyroptosis is a programmed cell death initiated by the activation of caspases, which is involved in the development and progression of several cardiovascular diseases. The gasdermins, a protein family, are key executive proteins in the development of pyroptosis, which increase cell membrane permeability, mediate the release of inflammatory factors, and aggravate the inflammatory injury. Traditional Chinese medicine(TCM)has shown unique therapeutic advantages in cardiovascular diseases with multi-component and multi-target characteristics. Currently, the effective prevention and treatment of cardiovascular diseases based on the theory of pyroptosis become a new research hotspot in this field. Based on the theories of TCM and modern medicine, this study summarized the role of pyroptosis in cardiovascular diseases such as atherosclerosis, myocardial infarction, diabetic cardiomyopathy, hypertension, and myocarditis. The role of TCM, including active monomers, crude extracts, and compound preparations, in cardiovascular protection through the regulation of pyroptosis was also summarized, providing a theoretical basis for the clinical prevention and treatment of cardiovascular diseases by TCM.
Humans
;
Medicine, Chinese Traditional
;
Drugs, Chinese Herbal/therapeutic use*
;
Cardiovascular Diseases/prevention & control*
;
Pyroptosis
;
Myocardial Infarction/drug therapy*


Result Analysis
Print
Save
E-mail